Oncternal TherapeuticsONCT
13F holders, Q2 2025 (June 30)1holders −3
1new positions
0sold out
$0.42avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Oncternal Therapeutics Inc. (ONCT) in their 13F filings, down 3 from Q4 2024. 1 opened new positions and 0 sold out. The largest holder was Union Bancaire Privee, UBP SA ($74).
- Company
- Oncternal Therapeutics Inc.
- CUSIP
- 68236P206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $74 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q2 2025: 175 shares bought, net +175 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Union Bancaire Privee, UBP SA | 0.00% | New | 175 | $74 |
"% of holder's portfolio" is ONCT's weight in each manager's 13F, not the share of Oncternal Therapeutics Inc. the manager owns.